Jyong Biotech Return on Investment 1971-1970 | MENS

Current and historical return on investment (ROI) values for Jyong Biotech (MENS) over the last 10 years.
Jyong Biotech ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.572B 0.00
Aduro Clean Technologies (ADUR) Canada $0.287B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Range Capital Acquisition (RANG) United States $0.143B 0.00
Tavia Acquisition (TAVI) $0.142B 0.00
YSX Tech (YSXT) China $0.121B 0.00
Youxin Technology (YAAS) China $0.118B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.091B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Uni-Fuels Holdings (UFG) $0.067B 0.00
Happy City Holdings (HCHL) $0.038B 0.00
PicoCELA (PCLA) Japan $0.030B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.022B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.016B 0.00
Sky Quarry (SKYQ) United States $0.016B 0.00
New Providence Acquisition III (NPAC) $0.000B 0.00
Slide Insurance Holdings (SLDE) United States $0.000B 0.00
Inflection Point Acquisition III (IPCX) $0.000B 0.00
ChampionsGate Acquisition (CHPG) $0.000B 0.00
Caris Life Sciences,�Inc (CAI) $0.000B 0.00